Latest epinephrine Stories
SILICON VALLEY, Calif., Sept. 14 /PRNewswire/ -- Mediaspectrum, Inc.Â® today introduced Adrenalin, the first complete solution for publishers seeking to create a customized news-reading application for Apple's iPad and other tablet devices.
BLUFFTON, S.C., July 1 /PRNewswire/ -- In the last 15 years, allergist Thomas C. Beller, M.D., founder of TCB Medical Devices (http://www.tcbmedicaldevices.com), has seen a relative allergy epidemic.
Weâ€™ve all experienced the strong heartbeat that accompanies emotions such as fear and rage.
Researchers have been able to see how heart failure affects the surface of an individual heart muscle cell in minute detail, using a new nanoscale scanning technique developed at Imperial College London.
NEW YORK, Feb.
RICHMOND, Va., Nov. 30 /PRNewswire/ -- Intelliject, Inc. today announced an exclusive license with sanofi-aventis U.S. for a novel epinephrine auto-injector, in the U.S. and Canada territory. Under the license, sanofi-aventis U.S. shall be responsible for manufacturing and commercialization.
BRIDGEWATER, N.J., Nov. 30 /PRNewswire-FirstCall/ -- Sanofi-aventis U.S. announced today the signing of an exclusive licensing agreement with Intelliject, Inc. for a novel epinephrine auto injector for the emergency treatment of allergic reactions (anaphylaxis) in North America (U.S. and Canada).
Patients with an out-of-hospital cardiac arrest who received intravenous (IV) drug administration during treatment, recommended in life support guidelines, had higher rates of short term survival but no statistically significant improvement in survival to hospital discharge or long-term survival.
NEW YORK, Nov.
NEW YORK, Nov.
- A poem in which the author retracts something said in an earlier poem.